January 8, 2018 11:59 AM EST
Pharma

Af­ter bumpy 2017, Cel­gene CEO says tak­ing risk is the on­ly way for­ward

Brittany Meiling

SAN FRAN­CIS­CO — Cel­gene’s CEO Mark Alles kicked off JPM this morn­ing re­as­sur­ing in­vestors that bets on new­ly-ac­quired as­sets will keep the com­pa­ny’s mo­men­tum …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times